Search

everythinglearnresearchcommunity

for

Search:↓

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Hair loss may indicate higher risk of heart disease.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Medications for PCOS don't seem to raise heart disease risk.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Human hair protein modifications could potentially indicate heart disease risk.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

DHT may increase the risk of heart disease and death in elderly men.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.